Published on: July 23, 2019 at 07:00PM
Condition: Type1diabetes
Interventions: Drug: Regular insulin (Humulin-R), intranasal route; Device: SipNose intranasal device
Sponsors: HealthPartners Institute; International Diabetes Center at Park Nicollet; Juvenile Diabetes Research Foundation
Not yet recruiting
No comments:
Post a Comment